Class II · Moderate riskTerminated Initiated Dec 12, 2012 (14 years ago)
Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Failed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the degradation product testing detected during stability monitoring.
What was recalled
Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral Administration, Rx Only, Cytotoxic, NDC: 0085-1519-02, Schering Corporation, Kenilworth, New Jersey, 07033
Recalling firm
Schering-Plough Products, LLC
Origin
PR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-139-2013
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.